SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : ProxyMed (PILL)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tom Gebing who wrote (193)12/6/1999 11:03:00 AM
From: Philip J. Davis   of 261
 
ProxyMed, Inc. Initiates Testing of its Lab EDI Connectivity

newsalert.com

>>- Quick Lab Rollout is Anticipated Upon Completion of Beta Period -

FORT LAUDERDALE, Fla., Dec. 6 /PRNewswire/ -- ProxyMed, Inc. (Nasdaq: PILL), a leading provider of Internet and private network-based healthcare connectivity services, today announced that it is testing the transmission of lab results reports through ProxyNet(R), its secure national healthcare information network. The beta testing is being conducted with three customers located in Oklahoma City, Oklahoma; Rockledge, Florida; and Omaha, Nebraska. The beta is scheduled to be completed in approximately thirty days, at which time the capability is expected to be ready for general release.<<
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext